Amanote Research

Amanote Research

    RegisterSign In

Drug Development for Cardiorenal Disease Based on Oxidative Stress Control

Yakugaku Zasshi - Japan
doi 10.1248/yakushi.13-00255-4
Full Text
Open PDF
Abstract

Available in full text

Categories
PharmacologyPharmaceutical Science
Date

January 1, 2014

Authors
Masaki ImanishiKeisuke IshizawaTakumi SakuradaYuki IshizawaNoriko YamanoYoshitaka KihiraYasumasa IkedaKoichiro TsuchiyaToshiaki Tamaki
Publisher

Pharmaceutical Society of Japan


Related search

Treatment Advances in Alzheimer’s Disease Based on the Oxidative Stress Model

F1000 Medicine Reports
2009English

The Drug Development Based on Pathogenetic Research in Alzheimer’s Disease

Advances in Alzheimer's Disease
2014English

Pharmacological Approach for Drug Repositioning Against Cardiorenal Diseases

Journal of Medical Investigation
BiochemistryMedicineGeneticsMolecular Biology
2017English

Special Issue on Oxidative Stress in Health and Disease

Cell Biochemistry and Biophysics
MedicineBiochemistryCell BiologyBiophysics
2013English

Oxidative Stress in Chronic Kidney Disease

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2018English

Oxidative Stress and Parkinson’s Disease: Effects on Environmental Toxicology

2016English

Oxidative Stress in Kawasaki Disease Vasculitis

International Journal of Pediatrics & Neonatal Care
2015English

Dry Eye Disease and Oxidative Stress

Acta Ophthalmologica
MedicineOphthalmology
2017English

Mycotoxins-Induced Oxidative Stress and Disease

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy